Inhibikase Therapeutics I... (IKT)

AI Score

Unlock

1.90

-0.08 (-4.04%)

At close: Apr 17, 2025, 3:59 PM

1.90

0.14%

After-hours: Apr 17, 2025, 06:38 PM EDT

Inhibikase Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q1 2019	Q4 2018	Q1 2018	Q4 2017	Q1 2017
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Mar 31, 2019	Dec 31, 2018	Mar 31, 2018	Dec 31, 2017	Mar 31, 2017
Cash & Equivalents	56.49M	913.42K	3.09M	2.35M	9.17M	14.86M	1.91M	3.96M	7.19M	5.78M	32.21M	36.61M	40.75M	44.85M	46.84M	9.61M	13.95M	16.17K	7.79K	13.14K	18.46K	-379.56K	379.56K	65.18K	16.66K	-12.04K
Short-Term Investments	41.05M	2.33M	4.85M	7.4M	4.09M	1.97M	19.03M	21.76M	15.86M	20.75M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	759.11K	n/a	n/a	n/a	24.07K
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	87.1K	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	-1	n/a	-363.62K	-534.75K	-565.17K	n/a	-43.09K	n/a	1.61M	n/a	n/a	2.78K	829.19K	1.43M	336.29K	10.63K	2.87K	-379.56K	1.59M	87.48K	n/a	-12.04K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	79.6K	64.52K	39.88K	13.84K	6.55K	47.98K	110.14K	217.48K	586.58K	332.77K	n/a	n/a	n/a	n/a	n/a	n/a	472.94K	147.25K	180.78K	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	425.23K	923.13K	1.12M	932.42K	919.05K	565.3K	107K	264.38K	958.78K	712.67K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	826.47K	834.23K	25K	25K	25K	371.54K	543.92K	922.76K	163.45K	505.92K	25K	1.17M	1.5M	541.39K	833.96K	1.22M	54.84K	n/a	n/a	n/a	16.92K	n/a	399.09K	n/a	625.00	n/a
Total Current Assets	98.45M	4.19M	8.6M	10.81M	14.21M	17.55M	21.98M	27.63M	24.37M	27.99M	33.95M	38.39M	42.47M	45.87M	49.22M	11.87M	14.78M	29.87K	30.35K	27.02K	35.38K	379.56K	1.25M	213.05K	198.07K	12.04K
Property-Plant & Equipment	148.54K	186.77K	224K	260.26K	295.6K	330.03K	363.62K	534.75K	565.17K	594.82K	43.09K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	148.54K	186.77K	224K	260.26K	295.6K	330.03K	363.62K	534.75K	565.17K	594.82K	43.09K	n/a	1.61M	n/a	n/a	2.78K	829.19K	1.43M	336.29K	10.63K	2.87K	-379.56K	1.59M	87.48K	87.1K	-12.04K
Total Assets	98.6M	4.38M	8.83M	11.07M	14.51M	17.88M	22.35M	28.16M	24.94M	28.58M	33.99M	38.39M	42.47M	45.87M	49.22M	11.87M	14.78M	1.46M	366.64K	37.66K	38.25K	n/a	2.85M	300.53K	285.17K	n/a
Account Payables	943.02K	2.53M	1.34M	1.29M	646.77K	734.56K	754.15K	959.08K	1.15M	781.22K	860.44K	806.2K	1.09M	553.8K	897.23K	715.02K	1.72M	3.31M	1.09M	753.53K	1M	n/a	954.24K	239.71K	353.52K	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	23.68K	23.68K	n/a	n/a	n/a	142.62K	1.25M	2.33M	1.96M	1.51M	1.47M	1.43M	n/a	262.37K	n/a	5.64K	n/a
Short-Term Debt	n/a	n/a	152.22K	n/a	381.78K	149.03K	147.97K	n/a	145.84K	142.05K	n/a	n/a	248.91K	248.91K	n/a	994.79K	42.53K	42.53K	42.53K	343.67K	98.42K	n/a	233.73K	444.52K	459.96K	n/a
Other Current Liabilities	999.3K	2.16M	1.57M	280.61K	n/a	1.06M	1.22M	n/a	1.79M	1.71M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.17M	201.32K	907.05K	n/a
Total Current Liabilities	3.73M	4.91M	3.7M	4.23M	3.44M	2.74M	2.73M	2.66M	3.7M	3.21M	4.49M	4.38M	4.05M	2.71M	1.91M	3.59M	4.72M	5.91M	4.57M	4.43M	4.25M	n/a	3.62M	1.7M	1.73M	n/a
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	248.91K	248.91K	276.46K	674.97K	626.84K	312.88K	275.38K	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	25.61K	58.33K	90.12K	121.01K	149.97K	178.11K	205.45K	232.02K	3.63M	806.2K	2.72M	1.91M	248.91K	248.91K	276.46K	674.97K	626.84K	312.88K	275.38K	n/a	n/a	n/a	n/a	n/a
Total Liabilities	3.73M	4.91M	3.73M	4.29M	3.53M	2.86M	2.88M	2.84M	3.9M	3.45M	4.49M	4.38M	4.05M	2.71M	2.16M	3.84M	5M	6.59M	5.2M	4.74M	4.53M	n/a	3.62M	1.7M	1.73M	n/a
Total Debt	110.52K	145.21K	177.83K	209.49K	622K	270.04K	297.94K	325.01K	351.29K	374.07K	n/a	n/a	248.91K	248.91K	248.91K	1.24M	319K	717.51K	669.37K	656.54K	373.79K	n/a	233.73K	444.52K	459.96K	n/a
Common Stock	69.36K	7.46K	7.22K	6.48K	6.19K	5.36K	5.29K	31.06K	25.23K	25.23K	25.23K	25.23K	25.16K	25.16K	25.13K	10.06K	10.05K	8.21K	8.19K	9.36K	8.18K	n/a	8.18K	8.92K	8.92K	n/a
Retained Earnings	-94.42M	-82.29M	-76.51M	-71.55M	-66.9M	-62.72M	-58.13M	-52.35M	-47.87M	-43.59M	-39.1M	-34.46M	-29.82M	-24.78M	-20.3M	-17.67M	-15.03M	-13.82M	-13.15M	-12.73M	-12.18M	n/a	-6.46M	-4.43M	-4.31M	n/a
Comprehensive Income	-37.25K	1.75K	-1.02K	-1.8K	877.00	-143	-1.71K	165.82K	104.72K	26.83K	n/a	n/a	-0.00	0.00	-0.00	n/a	0.00	0.00	n/a	0.00	n/a	-777.97K	n/a	n/a	n/a	-1.35M
Shareholders Equity	94.87M	-530.59K	5.1M	6.78M	10.98M	15.02M	19.46M	25.32M	21.04M	25.14M	29.5M	34.01M	38.42M	43.16M	47.05M	8.04M	9.78M	-5.13M	-4.83M	-4.7M	-4.49M	-777.97K	-777.97K	-1.4M	-1.44M	-1.35M
Total Investments	41.05M	2.33M	4.85M	7.4M	4.09M	1.97M	19.03M	21.76M	15.86M	20.75M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	759.11K	n/a	n/a	87.1K	24.07K